A Single Infusion Could Suppress H.I.V. for Years, Study Suggests

A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood ...

Poolbeg Pharma secures Canadian patent for cancer immunotherapy drug POLB 001

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian ...
Stocktwits on MSN

IBRX stock can't shake FDA delay overhang: Founder touts Saudi and Greece progress with Anktiva as bright spots

Soon-Shiong highlighted that ImmunityBio’s Quilt 3005 immunotherapy is already approved by the Saudi FDA. ・Investors are closely watching the FDA’s ongoing review of ImmunityBio’s resubmitted BLA for ...
News-Medical.Net

Slow and steady wins: Low-dose peanut immunotherapy safely desensitizes 82% of preschoolers in landmark trial

A Swedish randomized trial found that slow up-dosing peanut oral immunotherapy with a low maintenance dose helped 82% of ...